Top

Published in:

Open Access 01-12-2008 | Research

Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia

Authors: Christopher J Henry, Yan Huang, Angela Wynne, Mark Hanke, Justin Himler, Michael T Bailey, John F Sheridan, Jonathan P Godbout

Published in: Journal of Neuroinflammation | Issue 1/2008

Abstract

Background

Activation of the peripheral innate immune system stimulates the secretion of CNS cytokines that modulate the behavioral symptoms of sickness. Excessive production of cytokines by microglia, however, may cause long-lasting behavioral and cognitive complications. The purpose of this study was to determine if minocycline, an anti-inflammatory agent and purported microglial inhibitor, attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia.

Methods

In the first set of experiments the effect of minocycline pretreatment on LPS-induced microglia activation was assessed in BV-2 microglia cell cultures. In the second study, adult (3–6 m) BALB/c mice received an intraperitoneal (i.p.) injection of vehicle or minocycline (50 mg/kg) for three consecutive days. On the third day, mice were also injected (i.p.) with saline or Escherichia coli LPS (0.33 mg/kg) and behavior (i.e., sickness and anhedonia) and markers of neuroinflammation (i.e., microglia activation and inflammatory cytokines) were determined. In the final study, adult and aged BALB/c mice were treated with the same minocycline and LPS injection regimen and markers of neuroinflammation were determined. All data were analyzed using Statistical Analysis Systems General Linear Model procedures and were subjected to one-, two-, or three-way ANOVA to determine significant main effects and interactions.

Results

Minocycline blocked LPS-stimulated inflammatory cytokine secretion in the BV-2 microglia-derived cell line and reduced LPS-induced Toll-like-receptor-2 (TLR2) surface expression on brain microglia. Moreover, minocycline facilitated the recovery from sickness behavior (i.e., anorexia, weight loss, and social withdrawal) and prevented anhedonia in adult mice challenged with LPS. Furthermore, the minocycline associated recovery from LPS-induced sickness behavior was paralleled by reduced mRNA levels of Interleukin (IL)-1β, IL-6, and indoleamine 2, 3 dioxygenase (IDO) in the cortex and hippocampus. Finally, in aged mice, where exaggerated neuroinflammation was elicited by LPS, minocycline pretreatment was still effective in markedly reducing mRNA levels of IL-1β, TLR2 and IDO in the hippocampus.

Conclusion

These data indicate that minocycline mitigates neuroinflammation in the adult and aged brain and modulates the cytokine-associated changes in motivation and behavior.

Available only for authorised users

Kelley KW, Bluthe RM, Dantzer R, Zhou JH, Shen WH, Johnson RW, Broussard SR: Cytokine-induced sickness behavior. Brain Behav Immun. 2003, 17 (1 Suppl): 112-118. 10.1016/S0889-1591(02)00077-6.CrossRef

Konsman JP, Luheshi GN, Bluthe RM, Dantzer R: The vagus nerve mediates behavioural depression, but not fever, in response to peripheral immune signals; a functional anatomical analysis. Eur J Neurosci. 2000, 12 (12): 4434-4446. 10.1046/j.0953-816X.2000.01319.x.CrossRefPubMed

Goehler LE, Gaykema RP, Hammack SE, Maier SF, Watkins LR: Interleukin-1 induces c-Fos immunoreactivity in primary afferent neurons of the vagus nerve. Brain Res. 1998, 804 (2): 306-310. 10.1016/S0006-8993(98)00685-4.CrossRefPubMed

Laflamme N, Lacroix S, Rivest S: An essential role of interleukin-1beta in mediating NF-kappaB activity and COX-2 transcription in cells of the blood-brain barrier in response to a systemic and localized inflammation but not during endotoxemia. J Neurosci. 1999, 19 (24): 10923-10930.PubMed

Ching S, Zhang H, Belevych N, He L, Lai W, Pu XA, Jaeger LB, Chen Q, Quan N: Endothelial-specific knockdown of interleukin-1 (IL-1) type 1 receptor differentially alters CNS responses to IL-1 depending on its route of administration. J Neurosci. 2007, 27 (39): 10476-10486. 10.1523/JNEUROSCI.3357-07.2007.CrossRefPubMed

Nguyen MD, Julien JP, Rivest S: Innate immunity: the missing link in neuroprotection and neurodegeneration?. Nat Rev Neurosci. 2002, 3 (3): 216-227. 10.1038/nrn752.CrossRefPubMed

Heyser CJ, Masliah E, Samimi A, Campbell IL, Gold LH: Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain. Proc Natl Acad Sci U S A. 1997, 94 (4): 1500-1505. 10.1073/pnas.94.4.1500.PubMedCentralCrossRefPubMed

Vallieres L, Campbell IL, Gage FH, Sawchenko PE: Reduced hippocampal neurogenesis in adult transgenic mice with chronic astrocytic production of interleukin-6. J Neurosci. 2002, 22 (2): 486-492.PubMed

Barrientos RM, Higgins EA, Biedenkapp JC, Sprunger DB, Wright-Hardesty KJ, Watkins LR, Rudy JW, Maier SF: Peripheral infection and aging interact to impair hippocampal memory consolidation. Neurobiol Aging. 2006, 27 (5): 723-732. 10.1016/j.neurobiolaging.2005.03.010.CrossRefPubMed

10.

Chen J, Buchanan JB, Sparkman NL, Godbout JP, Freund GG, Johnson RW: Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system. Brain Behav Immun. 2008, 22 (3): 301-311. 10.1016/j.bbi.2007.08.014.PubMedCentralCrossRefPubMed

11.

Combrinck MI, Perry VH, Cunningham C: Peripheral infection evokes exaggerated sickness behaviour in pre-clinical murine prion disease. Neuroscience. 2002, 112 (1): 7-11. 10.1016/S0306-4522(02)00030-1.CrossRefPubMed

12.

Abraham J, Jang S, Godbout JP, Chen J, Kelley KW, Dantzer R, Johnson RW: Aging sensitizes mice to behavioral deficits induced by central HIV-1 gp120. Neurobiology of Aging. 29, 614-621. 2006, 29: 614-21. 10.1016/j.neurobiolaging.2006.11.002.CrossRef

13.

Godbout JP, Chen J, Abraham J, Richwine AF, Berg BM, Kelley KW, Johnson RW: Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system. Faseb J. 2005, 19 (10): 1329-1331.PubMed

14.

Huang Y, Henry CJ, Dantzer R, Johnson RW, Godbout JP: Exaggerated sickness behavior and brain proinflammatory cytokine expression in aged mice in response to intracerebroventricular lipopolysaccharide. Neurobiol Aging. 2007, Epub: May 30.

15.

Godbout JP, Moreau M, Lestage J, Chen J, Sparkman NL, Connor JO, Castanon N, Kelley KW, Dantzer R, Johnson RW: Aging Exacerbates Depressive-like Behavior in Mice in Response to Activation of the Peripheral Innate Immune System. Neuropsychopharmacology. 2007, Epub : Dec12.

16.

Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S, Littman DR, Dustin ML, Gan WB: ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci. 2005, 8 (6): 752-758. 10.1038/nn1472.CrossRefPubMed

17.

Nimmerjahn A, Kirchhoff F, Helmchen F: Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science. 2005, 308 (5726): 1314-1318. 10.1126/science.1110647.CrossRefPubMed

18.

Garden GA, Moller T: Microglia biology in health and disease. J Neuroimmune Pharmacol. 2006, 1 (2): 127-137. 10.1007/s11481-006-9015-5.CrossRefPubMed

19.

Perry VH, Newman TA, Cunningham C: The impact of systemic infection on the progression of neurodegenerative disease. Nat Rev Neurosci. 2003, 4 (2): 103-112. 10.1038/nrn1032.CrossRefPubMed

20.

Frank MG, Barrientos RM, Biedenkapp JC, Rudy JW, Watkins LR, Maier SF: mRNA up-regulation of MHC II and pivotal pro-inflammatory genes in normal brain aging. Neurobiol Aging. 2006, 27 (5): 717-722. 10.1016/j.neurobiolaging.2005.03.013.CrossRefPubMed

21.

Morgan TE, Xie Z, Goldsmith S, Yoshida T, Lanzrein AS, Stone D, Rozovsky I, Perry G, Smith MA, Finch CE: The mosaic of brain glial hyperactivity during normal ageing and its attenuation by food restriction. Neuroscience. 1999, 89 (3): 687-699. 10.1016/S0306-4522(98)00334-0.CrossRefPubMed

22.

Nicolle MM, Gonzalez J, Sugaya K, Baskerville KA, Bryan D, Lund K, Gallagher M, McKinney M: Signatures of hippocampal oxidative stress in aged spatial learning- impaired rodents. Neuroscience. 2001, 107 (3): 415-431. 10.1016/S0306-4522(01)00374-8.CrossRefPubMed

23.

Ogura K, Ogawa M, Yoshida M: Effects of ageing on microglia in the normal rat brain: immunohistochemical observations. Neuroreport. 1994, 5 (10): 1224-1226.CrossRefPubMed

24.

Perry VH, Matyszak MK, Fearn S: Altered antigen expression of microglia in the aged rodent CNS. Glia. 1993, 7 (1): 60-67. 10.1002/glia.440070111.CrossRefPubMed

25.

Sheffield LG, Berman NE: Microglial expression of MHC class II increases in normal aging of nonhuman primates. Neurobiol Aging. 1998, 19 (1): 47-55. 10.1016/S0197-4580(97)00168-1.CrossRefPubMed

26.

Sloane JA, Hollander W, Moss MB, Rosene DL, Abraham CR: Increased microglial activation and protein nitration in white matter of the aging monkey. Neurobiol Aging. 1999, 20 (4): 395-405. 10.1016/S0197-4580(99)00066-4.CrossRefPubMed

27.

Cunningham C, Wilcockson DC, Campion S, Lunnon K, Perry VH: Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J Neurosci. 2005, 25 (40): 9275-9284. 10.1523/JNEUROSCI.2614-05.2005.CrossRefPubMed

28.

Gaykema RP, Balachandran MK, Godbout JP, Johnson RW, Goehler LE: Enhanced neuronal activation in central autonomic network nuclei in aged mice following acute peripheral immune challenge. Auton Neurosci. 2006

29.

Lestage J, Verrier D, Palin K, Dantzer R: The enzyme indoleamine 2,3-dioxygenase is induced in the mouse brain in response to peripheral administration of lipopolysaccharide and superantigen. Brain Behav Immun. 2002, 16 (5): 596-601. 10.1016/S0889-1591(02)00014-4.CrossRefPubMed

30.

Moreau M, Lestage J, Verrier D, Mormede C, Kelley KW, Dantzer R, Castanon N: Bacille Calmette-Guerin inoculation induces chronic activation of peripheral and brain indoleamine 2,3-dioxygenase in mice. J Infect Dis. 2005, 192 (3): 537-544. 10.1086/431603.CrossRefPubMed

31.

Stone TW, Darlington LG: Endogenous kynurenines as targets for drug discovery and development. Nat Rev Drug Discov. 2002, 1 (8): 609-620. 10.1038/nrd870.CrossRefPubMed

32.

Capuron L, Ravaud A, Neveu PJ, Miller AH, Maes M, Dantzer R: Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol Psychiatry. 2002, 7 (5): 468-473. 10.1038/sj.mp.4000995.CrossRefPubMed

33.

Okuda S, Nishiyama N, Saito H, Katsuki H: 3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity. J Neurochem. 1998, 70 (1): 299-307.CrossRefPubMed

34.

Chiarugi A, Calvani M, Meli E, Traggiai E, Moroni F: Synthesis and release of neurotoxic kynurenine metabolites by human monocyte-derived macrophages. J Neuroimmunol. 2001, 120 (1-2): 190-198. 10.1016/S0165-5728(01)00418-0.CrossRefPubMed

35.

Behan WM, McDonald M, Darlington LG, Stone TW: Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenyl. Br J Pharmacol. 1999, 128 (8): 1754-1760. 10.1038/sj.bjp.0702940.PubMedCentralCrossRefPubMed

36.

Guillemin GJ, Smythe G, Takikawa O, Brew BJ: Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons. Glia. 2005, 49 (1): 15-23. 10.1002/glia.20090.CrossRefPubMed

37.

Raison CL, Capuron L, Miller AH: Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006, 27 (1): 24-31. 10.1016/j.it.2005.11.006.PubMedCentralCrossRefPubMed

38.

Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW: From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008, 9 (1): 46-56. 10.1038/nrn2297.PubMedCentralCrossRefPubMed

39.

Muller N, Schwarz MJ: The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. Mol Psychiatry. 2007, 12 (11): 988-1000. 10.1038/sj.mp.4002006.CrossRefPubMed

40.

Amin AR, Attur MG, Thakker GD, Patel PD, Vyas PR, Patel RN, Patel IR, Abramson SB: A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. Proc Natl Acad Sci U S A. 1996, 93 (24): 14014-14019. 10.1073/pnas.93.24.14014.PubMedCentralCrossRefPubMed

41.

Ekdahl CT, Claasen JH, Bonde S, Kokaia Z, Lindvall O: Inflammation is detrimental for neurogenesis in adult brain. Proc Natl Acad Sci U S A. 2003, 100 (23): 13632-13637. 10.1073/pnas.2234031100.PubMedCentralCrossRefPubMed

42.

Tomas-Camardiel M, Rite I, Herrera AJ, de Pablos RM, Cano J, Machado A, Venero JL: Minocycline reduces the lipopolysaccharide-induced inflammatory reaction, peroxynitrite-mediated nitration of proteins, disruption of the blood-brain barrier, and damage in the nigral dopaminergic system. Neurobiol Dis. 2004, 16 (1): 190-201. 10.1016/j.nbd.2004.01.010.CrossRefPubMed

43.

Griffin R, Nally R, Nolan Y, McCartney Y, Linden J, Lynch MA: The age-related attenuation in long-term potentiation is associated with microglial activation. J Neurochem. 2006, 99 (4): 1263-1272. 10.1111/j.1471-4159.2006.04165.x.CrossRefPubMed

44.

Nikodemova M, Duncan ID, Watters JJ: Minocycline exerts inhibitory effects on multiple mitogen-activated protein kinases and IkappaBalpha degradation in a stimulus-specific manner in microglia. J Neurochem. 2006, 96 (2): 314-323. 10.1111/j.1471-4159.2005.03520.x.CrossRefPubMed

45.

Nikodemova M, Watters JJ, Jackson SJ, Yang SK, Duncan ID: Minocycline down-regulates MHC II expression in microglia and macrophages through inhibition of IRF-1 and protein kinase C (PKC)alpha/betaII. J Biol Chem. 2007, 282 (20): 15208-15216. 10.1074/jbc.M611907200.CrossRefPubMed

46.

Zhu S, Stavrovskaya IG, Drozda M, Kim BY, Ona V, Li M, Sarang S, Liu AS, Hartley DM, Wu DC, Gullans S, Ferrante RJ, Przedborski S, Kristal BS, Friedlander RM: Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature. 2002, 417 (6884): 74-78. 10.1038/417074a.CrossRefPubMed

47.

Du Y, Ma Z, Lin S, Dodel RC, Gao F, Bales KR, Triarhou LC, Chernet E, Perry KW, Nelson DL, Luecke S, Phebus LA, Bymaster FP, Paul SM: Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Proc Natl Acad Sci U S A. 2001, 98 (25): 14669-14674. 10.1073/pnas.251341998.PubMedCentralCrossRefPubMed

48.

Nair A, Bonneau RH: Stress-induced elevation of glucocorticoids increases microglia proliferation through NMDA receptor activation. J Neuroimmunol. 2006, 171 (1-2): 72-85. 10.1016/j.jneuroim.2005.09.012.CrossRefPubMed

49.

Ford AL, Goodsall AL, Hickey WF, Sedgwick JD: Normal adult ramified microglia separated from other central nervous system macrophages by flow cytometric sorting. Phenotypic differences defined and direct ex vivo antigen presentation to myelin basic protein-reactive CD4+ T cells compared. J Immunol. 1995, 154 (9): 4309-4321.PubMed

50.

Craft TK, DeVries AC: Role of IL-1 in poststroke depressive-like behavior in mice. Biol Psychiatry. 2006, 60 (8): 812-818. 10.1016/j.biopsych.2006.03.011.CrossRefPubMed

51.

Skalisz LL, Beijamini V, Joca SL, Vital MA, Da Cunha C, Andreatini R: Evaluation of the face validity of reserpine administration as an animal model of depression--Parkinson's disease association. Prog Neuropsychopharmacol Biol Psychiatry. 2002, 26 (5): 879-883. 10.1016/S0278-5846(01)00333-5.CrossRefPubMed

52.

Godbout JP, Berg BM, Kelley KW, Johnson RW: alpha-Tocopherol reduces lipopolysaccharide-induced peroxide radical formation and interleukin-6 secretion in primary murine microglia and in brain. J Neuroimmunol. 2004, 149 (1-2): 101-109. 10.1016/j.jneuroim.2003.12.017.CrossRefPubMed

53.

Berg BM, Godbout JP, Kelley KW, Johnson RW: Alpha-tocopherol attenuates lipopolysaccharide-induced sickness behavior in mice. Brain Behav Immun. 2004, 18 (2): 149-157. 10.1016/S0889-1591(03)00113-2.CrossRefPubMed

54.

Yirmiya R: Endotoxin produces a depressive-like episode in rats. Brain Res. 1996, 711 (1-2): 163-174. 10.1016/0006-8993(95)01415-2.CrossRefPubMed

55.

De La Garza R: Endotoxin- or pro-inflammatory cytokine-induced sickness behavior as an animal model of depression: focus on anhedonia. Neurosci Biobehav Rev. 2005, 29 (4-5): 761-770. 10.1016/j.neubiorev.2005.03.016.CrossRefPubMed

56.

Quan N, Banks WA: Brain-immune communication pathways. Brain Behav Immun. 2007, 21 (6): 727-735. 10.1016/j.bbi.2007.05.005.CrossRefPubMed

57.

Evans DL, Charney DS, Lewis L, Golden RN, Gorman JM, Krishnan KR, Nemeroff CB, Bremner JD, Carney RM, Coyne JC, Delong MR, Frasure-Smith N, Glassman AH, Gold PW, Grant I, Gwyther L, Ironson G, Johnson RL, Kanner AM, Katon WJ, Kaufmann PG, Keefe FJ, Ketter T, Laughren TP, Leserman J, Lyketsos CG, McDonald WM, McEwen BS, Miller AH, Musselman D, O'Connor C, Petitto JM, Pollock BG, Robinson RG, Roose SP, Rowland J, Sheline Y, Sheps DS, Simon G, Spiegel D, Stunkard A, Sunderland T, Tibbits P, Valvo WJ: Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry. 2005, 58 (3): 175-189. 10.1016/j.biopsych.2005.05.001.CrossRefPubMed

58.

Penninx BW, Kritchevsky SB, Yaffe K, Newman AB, Simonsick EM, Rubin S, Ferrucci L, Harris T, Pahor M: Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study. Biol Psychiatry. 2003, 54 (5): 566-572. 10.1016/S0006-3223(02)01811-5.CrossRefPubMed

59.

Kremlev SG, Roberts RL, Palmer C: Differential expression of chemokines and chemokine receptors during microglial activation and inhibition. J Neuroimmunol. 2004, 149 (1-2): 1-9. 10.1016/j.jneuroim.2003.11.012.CrossRefPubMed

60.

Olson JK, Miller SD: Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol. 2004, 173 (6): 3916-3924.CrossRefPubMed

61.

Carson MJ, Thrash JC, Lo D: Analysis of microglial gene expression: identifying targets for CNS neurodegenerative and autoimmune disease. Am J Pharmacogenomics. 2004, 4 (5): 321-330. 10.2165/00129785-200404050-00005.CrossRefPubMed

62.

Godbout JP, Berg BM, Krzyszton C, Johnson RW: alpha-Tocopherol attenuates NFkappaB activation and pro-inflammatory cytokine production in brain and improves recovery from lipopolysaccharide-induced sickness behavior. J Neuroimmunol. 2005

63.

Berg BM, Godbout JP, Chen J, Kelley KW, Johnson RW: {alpha}-Tocopherol and Selenium Facilitate Recovery from Lipopolysaccharide-Induced Sickness in Aged Mice. J Nutr. 2005, 135 (5): 1157-1163.PubMed

64.

Godbout JP, Johnson RW: Age and neuroinflammation: a lifetime of psychoneuroimmune consequences. Neurol Clin. 2006, 24 (3): 521-538. 10.1016/j.ncl.2006.03.010.CrossRefPubMed

65.

Frenois F, Moreau M, O'Connor J, Lawson M, Micon C, Lestage J, Kelley KW, Dantzer R, Castanon N: Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior. Psychoneuroendocrinology. 2007, 32 (5): 516-531. 10.1016/j.psyneuen.2007.03.005.PubMedCentralCrossRefPubMed

66.

O'Connor JC, Lawson MA, Andre C, Moreau M, Lestage J, Castanon N, Kelley KW, Dantzer R: Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry. 2008

67.

Muramami N, Fukata J, Tsukada T, Kobayashi H, Ebisui O, Segawa H, Muro S, Imura H, Nakao K: Bacterial lipopolysaccharide-induced expression of interleukin-6 messenger ribonucleic acid in the rat hypothalamus, pituitary, adrenal gland, and spleen. Endocrinology. 1993, 133 (6): 2574-2578. 10.1210/en.133.6.2574.PubMed

68.

Finck BN, Dantzer R, Kelley KW, Woods JA, Johnson RW: Central lipopolysaccharide elevates plasma IL-6 concentration by an alpha-adrenoreceptor-mediated mechanism. Am J Physiol. 1997, 272 (6 Pt 2): R1880-7.PubMed

69.

Finck BN, Johnson RW: Anorexia, weight loss and increased plasma interleukin-6 caused by chronic intracerebroventricular infusion of interleukin-1beta in the rat. Brain Res. 1997, 761 (2): 333-337. 10.1016/S0006-8993(97)00451-4.CrossRefPubMed

70.

Ye SM, Johnson RW: Increased interleukin-6 expression by microglia from brain of aged mice. J Neuroimmunol. 1999, 93 (1-2): 139-148. 10.1016/S0165-5728(98)00217-3.CrossRefPubMed

Title: Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia
Authors: Christopher J Henry
Yan Huang
Angela Wynne
Mark Hanke
Justin Himler
Michael T Bailey
John F Sheridan
Jonathan P Godbout
Publication date: 01-12-2008
Publisher: BioMed Central
Published in: Journal of Neuroinflammation / Issue 1/2008
Electronic ISSN: 1742-2094
DOI: https://doi.org/10.1186/1742-2094-5-15

At a glance: The STEP trials

Springer Medicine

Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia

Abstract

Background

Methods

Results

Conclusion

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2008

Does gamma-aminobutyric acid (GABA) influence the development of chronic inflammation in rheumatoid arthritis?

Characterization of early and terminal complement proteins associated with polymorphonuclear leukocytes in vitro and in vivo after spinal cord injury

Sepsis causes neuroinflammation and concomitant decrease of cerebral metabolism

Immune modulation and increased neurotrophic factor production in multiple sclerosis patients treated with testosterone

Histoplasma capsulatum yeast phase-specific protein Yps3p induces Toll-like receptor 2 signaling

Kinin B2receptor regulates chemokines CCL2 and CCL5 expression and modulates leukocyte recruitment and pathology in experimental autoimmune encephalomyelitis (EAE) in mice